Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory, and metabolic diseases. Arena's lead product candidate, lorcaserin, is in a Phase III clinical trial program for the treatment of obesity.

Report Highlights
Arena is a California-based biopharmaceutical company specializing in the discovery and development of agents that target GPCRs. The company currently concentrates on developing drugs, independently or with partners, for the potential treatment of obesity, insomnia, diabetes and atherosclerosis and related diseases. The company generated revenues from its collaborative agreements with Ortho-McNeil and Merck during 2002-2006. License, collaboration and other revenues increased at a CAGR of 12% from $19 million in 2002 to $31 million in 2006. The company's total revenues are forecast to increase at a CAGR of 46% during 2006-2010, from $31 million to $139 million. The collaborative and license revenues will be the major contributors of total revenue growth.
[Studien Infos ausblenden]

Table 1: Arena Pharmaceuticals - Key Facts 6
Table 2: Arena Pharmaceuticals - Year-End Share Price and Market Capitalization, 2002-2006 ($) 13
Table 3: Arena Pharmaceuticals - Key Events Impacting Share Price Performance 13
Table 4: Arena Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 14
Table 5: Arena Pharmaceuticals - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 16
Table 6: Arena Pharmaceuticals – Balance Sheet, 2002-2006 ($ Mn) 17
Table 7: Arena Pharmaceuticals – Cash Flow, 2002-2006 ($ Mn) 17
Table 8: Arena Pharmaceuticals - In-house Pipeline Products 18
Table 9: Arena Pharmaceuticals - Collaboration Pipeline 19
Table 10: Arena Pharmaceuticals – Key Strategic Revenues (2006-2010) 21
Table 11: Arena Pharmaceuticals - Key Competitors 23
Table 12: Arena Pharmaceuticals - Key Clients 24
Table 13: Arena Pharmaceuticals - Key Shareholders 25
Table 14: Arena Pharmaceuticals - SWOT Analysis Summary 29
Table 15: Arena Pharmaceuticals – Value Chain Analysis 35
Table 16: Arena Pharmaceuticals – Scorecard 36
Table 17: Arena Pharmaceuticals - Key Employees 38
Table 18: Arena Pharmaceuticals - Financial and Operational Overview 47
Figure 1: Arena Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 15

Figure 2: Arena Pharmaceuticals - Key Strategic Products Revenues, 2006-2010 ($ Mn) 22
[Tabellenverzeichnis ausblenden]